These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36375125)

  • 21. HU for SCA in Africa: associated malaria benefit.
    Odame I
    Blood; 2023 Mar; 141(12):1370-1371. PubMed ID: 36951885
    [No Abstract]   [Full Text] [Related]  

  • 22. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.
    Hankins JS; Aygun B; Nottage K; Thornburg C; Smeltzer MP; Ware RE; Wang WC
    Medicine (Baltimore); 2014 Dec; 93(28):e215. PubMed ID: 25526439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea.
    Santos B; Ginete C; Gonçalves E; Delgadinho M; Miranda A; Faustino P; Arez AP; Brito M
    Blood Cells Mol Dis; 2024 Mar; 105():102822. PubMed ID: 38215581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
    Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
    Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
    Bello-Manga H; DeBaun MR; Kassim AA
    Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
    Aygun B; Mortier NA; Smeltzer MP; Shulkin BL; Hankins JS; Ware RE
    Am J Hematol; 2013 Feb; 88(2):116-9. PubMed ID: 23255310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
    Kinney TR; Helms RW; O'Branski EE; Ohene-Frempong K; Wang W; Daeschner C; Vichinsky E; Redding-Lallinger R; Gee B; Platt OS; Ware RE
    Blood; 1999 Sep; 94(5):1550-4. PubMed ID: 10477679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
    Abdullahi SU; Wudil BJ; Bello-Manga H; Musa AB; Gambo S; Galadanci NA; Aminu H; Tijjani Gaya A; Sanusi S; Tabari MA; Galadanci A; Borodo A; Abba MS; Dambatta AH; Haliru L; Gambo A; Cassell H; Rodeghier M; Ghafuri DL; Covert Greene BV; Neville K; Kassim AA; Kirkham F; Trevathan E; Jordan LC; Aliyu MH; DeBaun MR
    Pediatr Hematol Oncol; 2021 Feb; 38(1):49-64. PubMed ID: 33236662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT).
    Uyoga S; Olupot-Olupot P; Connon R; Kiguli S; Opoka RO; Alaroker F; Muhindo R; Macharia AW; Dondorp AM; Gibb DM; Walker AS; George EC; Maitland K; Williams TN
    Lancet Child Adolesc Health; 2022 Sep; 6(9):606-613. PubMed ID: 35785794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea therapy for sickle cell anemia.
    McGann PT; Ware RE
    Expert Opin Drug Saf; 2015; 14(11):1749-58. PubMed ID: 26366626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.
    Estepp JH; Winter B; Johnson M; Smeltzer MP; Howard SC; Hankins JS
    Pediatr Blood Cancer; 2014 Nov; 61(11):2031-6. PubMed ID: 25132074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia.
    Sheehan VA; Crosby JR; Sabo A; Mortier NA; Howard TA; Muzny DM; Dugan-Perez S; Aygun B; Nottage KA; Boerwinkle E; Gibbs RA; Ware RE; Flanagan JM
    PLoS One; 2014; 9(10):e110740. PubMed ID: 25360671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia.
    Power-Hays A; Dong M; Punt N; Mizuno T; Smart LR; Vinks AA; Ware RE
    Clin Pharmacol Ther; 2024 Sep; 116(3):670-677. PubMed ID: 38018175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Luchtman-Jones L; Pressel S; Hilliard L; Brown RC; Smith MG; Thompson AA; Lee MT; Rothman J; Rogers ZR; Owen W; Imran H; Thornburg C; Kwiatkowski JL; Aygun B; Nelson S; Roberts C; Gauger C; Piccone C; Kalfa T; Alvarez O; Hassell K; Davis BR; Ware RE
    Am J Hematol; 2016 Feb; 91(2):238-42. PubMed ID: 26615793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.
    Zimmerman SA; Schultz WH; Davis JS; Pickens CV; Mortier NA; Howard TA; Ware RE
    Blood; 2004 Mar; 103(6):2039-45. PubMed ID: 14630791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An age dependent response to hydroxyurea in pediatric sickle cell anemia patients with alpha thalassemia trait.
    Figueiredo L; Morrone K; Wei C; Ireland K; Cohen HW; Driscoll C; Manwani D
    Blood Cells Mol Dis; 2017 Jul; 66():19-23. PubMed ID: 28783617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Digestives diseases associated to sickle cell anemia in Lubumbashi: epidemiological and clinical aspects].
    Banza MI; Mulefu JP; Lire LI; N'dwala YTB; Tshiamala IB; Cabala VPK
    Pan Afr Med J; 2019; 33():253. PubMed ID: 31692839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective use of hydroxyurea for sickle cell anemia in low-resource countries.
    Power-Hays A; Ware RE
    Curr Opin Hematol; 2020 May; 27(3):172-180. PubMed ID: 32205588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical epidemiology of sickle cell anemia In Africa.
    Macharia AW; Mochamah G; Uyoga S; Ndila CM; Nyutu G; Makale J; Tendwa M; Nyatichi E; Ojal J; Shebe M; Awuondo KO; Mturi N; Peshu N; Tsofa B; Scott JAG; Maitland K; Williams TN
    Am J Hematol; 2018 Mar; 93(3):363-370. PubMed ID: 29168218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.